{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T16:57:29Z","timestamp":1782406649256,"version":"3.54.5"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T00:00:00Z","timestamp":1655164800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T00:00:00Z","timestamp":1655164800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Inherited retinal degenerations (IRDs) affect daylight and night vision to different degrees. In the current work, we devise a method to quantify mobility under dark-adapted conditions in patients with severe childhood blindness due to Leber congenital amaurosis (LCA). Mobility thresholds from two different LCA genotypes are compared to dark-adapted vision measurements using the full-field stimulus test (FST), a conventional desktop outcome measure of rod vision.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A device consisting of vertical LED strips on a plane resembling a beaded curtain was programmed to produce a rectangular pattern target defining a \u2018door\u2019 of varying luminance that could appear at one of three positions. Mobility performance was evaluated by letting the subject walk from a fixed starting position\u2009~\u20094\u00a0m away from the device with instructions to touch the door. Success was defined as the subject touching within the \u2018door\u2019 area. Ten runs were performed and the process was repeated for different levels of luminance. Tests were performed monocularly in dark-adapted and dilated eyes. Results from LCA patients with the <jats:italic>GUCY2D<\/jats:italic> and <jats:italic>CEP290<\/jats:italic> genotypes and normal subjects were analyzed using logistic regression to estimate the mobility threshold for successful navigation. The relation of thresholds for mobility, FST and visual acuity were quantified using linear regression.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Normal subjects had mobility thresholds near limits of dark-adapted rod vision. <jats:italic>GUCY2D<\/jats:italic>-LCA patients had a wide range of mobility thresholds from within 1 log of normal to greater than 8 log abnormal. <jats:italic>CEP290<\/jats:italic>-LCA patients had abnormal mobility thresholds that were between 5 and 6 log from normal. Sensitivity loss estimates using FST related linearly to the mobility thresholds which were not correlated with visual acuity.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The mobility task we developed can quantify functional vision in severely disabled patients with LCA. Taken together with other outcome measures of rod and cone photoreceptor-mediated vision, dark-adapted functional vision should provide a more complete understanding of the natural history and effects of treatment in patients with LCA.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12886-022-02475-y","type":"journal-article","created":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T11:03:08Z","timestamp":1655204588000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Mobility test to assess functional vision in dark-adapted patients with Leber congenital amaurosis"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7368-3007","authenticated-orcid":false,"given":"Alejandro J.","family":"Roman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2018-0905","authenticated-orcid":false,"given":"Artur V.","family":"Cideciyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham A.","family":"Mascio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun K.","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra V.","family":"Garafalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2122-169X","authenticated-orcid":false,"given":"Samuel G.","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,14]]},"reference":[{"key":"2475_CR1","doi-asserted-by":"crossref","unstructured":"Csaky KG, Richman EA, Ferris FL 3rd. Report from the NEI\/FDA ophthalmic clinical trial design and endpoints symposium. Invest Ophthalmol Vis Sci. 2008;49(2):479 \u2013 89.","DOI":"10.1167\/iovs.07-1132"},{"issue":"12","key":"2475_CR2","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1016\/S0161-6420(86)33522-X","volume":"93","author":"SG Jacobson","year":"1986","unstructured":"Jacobson SG, Voigt WJ, Parel JM, Apathy PP, Nghiem-Phu L, Myers SW, Patella VM. Automated light- and dark-adapted perimetry for evaluating retinitis pigmentosa. Ophthalmology. 1986;93(12):1604\u201311.","journal-title":"Ophthalmology"},{"key":"2475_CR3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1471-2415-11-5","volume":"11","author":"MD Crossland","year":"2011","unstructured":"Crossland MD, Luong VA, Rubin GS, Fitzke FW. Retinal specific measurement of dark-adapted visual function: validation of a modified microperimeter. BMC Ophthalmol. 2011;11:5.","journal-title":"BMC Ophthalmol"},{"key":"2475_CR4","doi-asserted-by":"crossref","unstructured":"Cideciyan AV, Krishnan AK, Roman AJ, Sumaroka A, Swider M, Jacobson SG. 2021. Measures of function and structure to determine phenotypic features, natural history, and treatment outcomes in inherited retinal diseases. Annu Rev Vis Sci. 2021;7:747 \u2013 72.","DOI":"10.1146\/annurev-vision-032321-091738"},{"key":"2475_CR5","doi-asserted-by":"crossref","unstructured":"Krishnan AK, Roman AJ, Swider M, Jacobson SG, Cideciyan AV. Macular rod function in retinitis pigmentosa measured with scotopic microperimetry. Transl Vis Sci Technol. 2021;10(11):3.","DOI":"10.1167\/tvst.10.11.3"},{"key":"2475_CR6","doi-asserted-by":"publisher","first-page":"101000","DOI":"10.1016\/j.preteyeres.2021.101000","volume":"87","author":"AJ Roman","year":"2022","unstructured":"Roman AJ, Cideciyan AV, Wu V, Garafalo AV, Jacobson SG. Full-field stimulus testing: Role in the clinic and as an outcome measure in clinical trials of severe childhood retinal disease. Prog Retin Eye Res. 2022;87:101000.","journal-title":"Prog Retin Eye Res"},{"issue":"6","key":"2475_CR7","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1167\/iovs.03-1061","volume":"45","author":"DT Hartong","year":"2004","unstructured":"Hartong DT, Jorritsma FF, Neve JJ, Melis-Dankers BJ, Kooijman AC. Improved mobility and independence of night-blind people using night-vision goggles. Invest Ophthalmol Vis Sci. 2004 Jun;45(6):1725\u201331.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"2475_CR8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1001\/archophthalmol.2011.298","volume":"130","author":"SG Jacobson","year":"2012","unstructured":"Jacobson SG, Cideciyan AV, Ratnakaram R, Heon E, Schwartz SB, Roman AJ, Peden MC, Aleman TS, Boye SL, Sumaroka A, Conlon TJ, Calcedo R, Pang JJ, Erger KE, Olivares MB, Mullins CL, Swider M, Kaushal S, Feuer WJ, Iannaccone A, Fishman GA, Stone EM, Byrne BJ, Hauswirth WW. Gene therapy for Leber congenital amaurosis caused by RPE65 mutations: safety and efficacy in 15 children and adults followed up to 3 years. Arch Ophthalmol. 2012 Jan;130(1):9\u201324.","journal-title":"Arch Ophthalmol"},{"issue":"8","key":"2475_CR9","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1016\/j.ophtha.2015.04.032","volume":"122","author":"AC Ho","year":"2015","unstructured":"Ho AC, Humayun MS, Dorn JD, da Cruz L, Dagnelie G, Handa J, Barale PO, Sahel JA, Stanga PE, Hafezi F, Safran AB, Salzmann J, Santos A, Birch D, Spencer R, Cideciyan AV, de Juan E, Duncan JL, Eliott D, Fawzi A, Olmos de Koo LC, Brown GC, Haller JA, Regillo CD, Del Priore LV, Arditi A, Geruschat DR, Greenberg RJ. Argus II Study Group. Long-term results from an epiretinal prosthesis to restore sight to the blind. Ophthalmology. 2015 Aug;122(8):1547\u201354.","journal-title":"Ophthalmology"},{"issue":"3","key":"2475_CR10","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/ceo.13022","volume":"46","author":"DC Chung","year":"2018","unstructured":"Chung DC, McCague S, Yu ZF, Thill S, DiStefano-Pappas J, Bennett J, Cross D, Marshall K, Wellman J, High KA. Novel mobility test to assess functional vision in patients with inherited retinal dystrophies. Clin Exp Ophthalmol. 2018 Apr;46(3):247\u201359.","journal-title":"Clin Exp Ophthalmol"},{"issue":"2","key":"2475_CR11","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41591-018-0295-0","volume":"25","author":"AV Cideciyan","year":"2019","unstructured":"Cideciyan AV, Jacobson SG, Drack AV, Ho AC, Charng J, Garafalo AV, Roman AJ, Sumaroka A, Han IC, Hochstedler MD, Pfeifer WL, Sohn EH, Taiel M, Schwartz MR, Biasutto P, de Wit W, Cheetham ME, Adamson P, Rodman DM, Platenburg G, Tome MD, Balikova I, Nerinckx F, De Zaeytijd J, Van Cauwenbergh C, Leroy BP, Russell SR. Effect of an intravitreal antisense oligonucleotide on vision in Leber congenital amaurosis due to a photoreceptor cilium defect. Nat Med. 2019;25(2):225\u20138.","journal-title":"Nat Med"},{"key":"2475_CR12","doi-asserted-by":"crossref","unstructured":"Kumaran N, Ali RR, Tyler NA, Bainbridge JWB, Michaelides M, Rubin GS. Validation of a vision-guided mobility assessment for RPE65-associated retinal dystrophy. Transl Vis Sci Technol. 2020;9(10):5.","DOI":"10.1167\/tvst.9.10.5"},{"key":"2475_CR13","doi-asserted-by":"crossref","unstructured":"Aleman TS, Miller AJ, Maguire KH, Aleman EM, Serrano LW, O\u2019Connor KB, Bedoukian EC, Leroy BP, Maguire AM, Bennett J. A virtual reality orientation and mobility test for inherited retinal degenerations: testing a proof-of-concept after gene therapy. Clin Ophthalmol. 2021;15:939 \u2013 52.","DOI":"10.2147\/OPTH.S292527"},{"key":"2475_CR14","doi-asserted-by":"crossref","unstructured":"Roman AJ, Cideciyan AV, Matsui R, Sheplock R, Schwartz SB, Jacobson SG. Outcome measure for the treatment of cone photoreceptor diseases: orientation to a scene with cone-only contrast. BMC Ophthalmol. 2015;15:98.","DOI":"10.1186\/s12886-015-0085-0"},{"issue":"2","key":"2475_CR15","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.exer.2004.09.008","volume":"80","author":"AJ Roman","year":"2005","unstructured":"Roman AJ, Schwartz SB, Aleman TS, Cideciyan AV, Chico JD, Windsor EAM, Gardner LM, Ying G, Smiko EE, Maguire MG, Jacobson SG. Quantifying rod photoreceptor-mediated vision in retinal degenerations: dark-adapted thresholds as outcome measures. Exp Eye Res. 2005;80(2):259\u201372.","journal-title":"Exp Eye Res"},{"issue":"8","key":"2475_CR16","doi-asserted-by":"publisher","first-page":"N51","DOI":"10.1088\/0967-3334\/28\/8\/N02","volume":"28","author":"AJ Roman","year":"2007","unstructured":"Roman AJ, Cideciyan AV, Aleman TS, Jacobson SG. Full-field stimulus testing (FST) to quantify visual perception in severely blind candidates for treatment trials. Physiol Meas. 2007;28(8):N51\u20136.","journal-title":"Physiol Meas"},{"key":"2475_CR17","doi-asserted-by":"publisher","unstructured":"Koller M. robustlmm: An R package for robust estimation of linear mixed-effects models. J Statistical Software. 2016;75(6): 1\u201324 https:\/\/doi.org\/10.18637\/22.075\/jss.v075.i06.","DOI":"10.18637\/22.075\/jss.v075.i06"},{"key":"2475_CR18","unstructured":"R Core Team. R: a language and environment for statistical computing. R Foundation for Statistical Computing, 2021: Vienna, Austria. https:\/\/www.R-project.org\/."},{"issue":"1","key":"2475_CR19","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1093\/hmg\/dds421","volume":"22","author":"SG Jacobson","year":"2013","unstructured":"Jacobson SG, Cideciyan AV, Peshenko IV, Sumaroka A, Olshevskaya EV, Cao L, Schwartz SB, Roman AJ, Olivares MB, Sadigh S, et al. Determining consequences of retinal membrane guanylyl cyclase (RetGC1) deficiency in human Leber congenital amaurosis en route to therapy: residual cone-photoreceptor vision correlates with biochemical properties of the mutants. Hum Mol Genet. 2013;22(1):168\u201383.","journal-title":"Hum Mol Genet"},{"key":"2475_CR20","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ajo.2017.02.003","volume":"177","author":"SG Jacobson","year":"2017","unstructured":"Jacobson SG, Cideciyan AV, Sumaroka A, Roman AJ, Charng J, Lu M, Choudhury S, Schwartz SB, Heon E, Fishman GA, Boye SE. Defining outcomes for clinical trials of Leber congenital amaurosis caused by GUCY2D mutations. Am J Ophthalmol. 2017;177:44\u201357.","journal-title":"Am J Ophthalmol"},{"issue":"11","key":"2475_CR21","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1002\/humu.20565","volume":"28","author":"AV Cideciyan","year":"2007","unstructured":"Cideciyan AV, Aleman TS, Jacobson SG, Khanna H, Sumaroka A, Aguirre GK, Schwartz SB, Windsor EA, He S, Chang B, Stone EM, Swaroop A. Centrosomal-ciliary gene CEP290\/NPHP6 mutations result in blindness with unexpected sparing of photoreceptors and visual brain: implications for therapy of Leber congenital amaurosis. Hum Mutat. 2007;28(11):1074\u201383.","journal-title":"Hum Mutat"},{"key":"2475_CR22","doi-asserted-by":"crossref","unstructured":"Jacobson SG, Cideciyan AV, Sumaroka A, Roman AJ, Charng J, Lu M, Choi W, Sheplock R, Swider M, Kosyk MS, Schwartz SB, Stone EM, Fishman GA. Outcome measures for clinical trials of Leber congenital amaurosis caused by the intronic mutation in the CEP290 gene. Invest Ophthalmol Vis Sci. 2017;58(5):2609-22.","DOI":"10.1167\/iovs.17-21560"},{"key":"2475_CR23","doi-asserted-by":"crossref","unstructured":"Cideciyan AV, Jacobson SG. Leber congenital amaurosis (LCA): potential for improvement of vision. Invest Ophthalmol Vis Sci. 2019;60(5):1680-95.","DOI":"10.1167\/iovs.19-26672"},{"key":"2475_CR24","doi-asserted-by":"crossref","unstructured":"Lamb TD. Why rods and cones? Eye (Lond). 2016;30(2):179\u201385.","DOI":"10.1038\/eye.2015.236"},{"key":"2475_CR25","doi-asserted-by":"crossref","unstructured":"Ingram NT, Sampath AP, Fain GL. Why are rods more sensitive than cones? J Physiol. 2016;594(19):5415-26.","DOI":"10.1113\/JP272556"},{"issue":"4","key":"2475_CR26","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.preteyeres.2008.05.003","volume":"27","author":"AI den Hollander","year":"2008","unstructured":"den Hollander AI, Roepman R, Koenekoop RK, Cremers FP. Leber congenital amaurosis: genes, proteins and disease mechanisms. Prog Retin Eye Res. 2008;27(4):391\u2013419.","journal-title":"Prog Retin Eye Res"},{"key":"2475_CR27","doi-asserted-by":"crossref","unstructured":"Chacon-Camacho OF, Zenteno JC. Review and update on the molecular basis of Leber congenital amaurosis. World J Clin Cases. 2015;3(2):112\u201324.","DOI":"10.12998\/wjcc.v3.i2.112"},{"key":"2475_CR28","unstructured":"Kumaran N, Pennesi ME, Yang P, Trzupek KM, Schlechter C, Moore AT, Weleber RG, Michaelides M. Leber Congenital Amaurosis \/ Early-Onset Severe Retinal Dystrophy Overview. 2018 Oct 4. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Mirzaa G, Amemiya A, editors. GeneReviews\u00ae. Seattle: University of Washington, Seattle; 1993\u20132021."},{"key":"2475_CR29","doi-asserted-by":"crossref","unstructured":"Hauswirth WW, Aleman TS, Kaushal S, Cideciyan AV, Schwartz SB, Wang L, Conlon TJ, Boye SL, Flotte TR, Byrne BJ, Jacobson SG. Treatment of Leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial. Hum Gene Ther. 2008;19(10):979\u201390.","DOI":"10.1089\/hum.2008.107"},{"issue":"21","key":"2475_CR30","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1056\/NEJMoa0802268","volume":"358","author":"JWB Bainbridge","year":"2008","unstructured":"Bainbridge JWB, Smith AJ, Barker SS, Robbie S, Henderson R, Balaggan K, Viswanathan A, Holder GE, Stockman A, Tyler N, Peterson-Jones S, Bhattacharya SS, Thrasher AJ, Fitzke FW, Carter BJ, Rubin GS, Moore AT, Ali RR. Effect of gene therapy on visual function in Leber\u2019s congenital amaurosis. N Engl J Med. 2008;358(21):2231\u20139.","journal-title":"N Engl J Med"},{"issue":"21","key":"2475_CR31","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1056\/NEJMoa0802315","volume":"358","author":"AM Maguire","year":"2008","unstructured":"Maguire AM, Simonelli F, Pierce EA, Pugh EN Jr, Mingozzi F, Bennicelli J, Banfi S, Marshall KA, Testa F, Surace EM, Rossi S, Lyubarsky A, Arruda VR, Konkle B, Stone E, Sun J, Jacobs J, Dell\u2019Osso L, Hertle R, Ma J, Redmond M, Zhu X, Hauck B, Zelenaia O, Shindler KS, Maguire MG, Wright JF, Volpe NJ, McDonnell JW, Auricchio A, High KA, Bennett J. Safety and efficacy of gene transfer for Leber\u2019s congenital amaurosis. N Engl J Med. 2008;358(21):2240\u20138.","journal-title":"N Engl J Med"},{"issue":"39","key":"2475_CR32","doi-asserted-by":"publisher","first-page":"15112","DOI":"10.1073\/pnas.0807027105","volume":"105","author":"AV Cideciyan","year":"2008","unstructured":"Cideciyan AV, Aleman TS, Boye SL, Schwartz SB, Kaushal S, Roman AJ, Pang JJ, Sumaroka A, Windsor EA, Wilson JM, Flotte TR, Fishman GA, Heon E, Stone EM, Byrne BJ, Jacobson SG, Hauswirth WW. Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics. Proc Natl Acad Sci USA. 2008;105(39):15112\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"2475_CR33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1001\/archophthalmol.2011.298","volume":"130","author":"SG Jacobson","year":"2012","unstructured":"Jacobson SG, Cideciyan AV, Ratnakaram R, Heon E, Schwartz SB, Roman AJ, Peden MC, Aleman TS, Boye SL, Sumaroka A, Conlon TJ, Calcedo R, Pang JJ, Erger KE, Olivares MB, Mullins CL, Swider M, Kaushal S, Feuer WJ, Iannaccone A, Fishman GA, Stone EM, Byrne BJ, Hauswirth WW. Gene therapy for Leber congenital amaurosis caused by RPE65 mutations: safety and efficacy in 15 children and adults followed up to 3 years. Arch Ophthalmol. 2012;130(1):9\u201324.","journal-title":"Arch Ophthalmol"},{"issue":"9","key":"2475_CR34","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1097\/OPX.0000000000000891","volume":"93","author":"RP Finger","year":"2016","unstructured":"Finger RP, Ayton LN, Deverell L, O\u2019Hare F, McSweeney SC, Luu CD, Fenwick EK, Keeffe JE, Guymer RH, Bentley SA. Developing a very low vision orientation and mobility test battery. Optom Vis Sci. 2016;93(9):1127\u201336.","journal-title":"Optom Vis Sci"},{"issue":"9","key":"2475_CR35","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/j.ophtha.2019.06.017","volume":"126","author":"AM Maguire","year":"2019","unstructured":"Maguire AM, Russell S, Wellman JA, Chung DC, Yu ZF, Tillman A, Wittes J, Pappas J, Elci O, Marshall KA, McCague S, Reichert H, Davis M, Simonelli F, Leroy BP, Wright JF, High KA, Bennett J. Efficacy, safety, and durability of voretigene neparvovec-rzyl in RPE65 mutation-associated inherited retinal dystrophy: results of Phase 1 and 3 Trials. Ophthalmology. 2019;126(9):1273\u201385.","journal-title":"Ophthalmology"},{"issue":"4","key":"2475_CR36","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/ng1296-461","volume":"14","author":"I Perrault","year":"1996","unstructured":"Perrault I, Rozet JM, Calvas P, Gerber S, Camuzat A, Dollfus H, Ch\u00e2telin S, Souied E, Ghazi I, Leowski C, Bonnemaison M, Le Paslier D, Fr\u00e9zal J, Dufier JL, Pittler S, Munnich A, Kaplan J. Retinal-specific guanylate cyclase gene mutations in Leber\u2019s congenital amaurosis. Nat Genet. 1996;14(4):461\u20134.","journal-title":"Nat Genet"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-022-02475-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-022-02475-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-022-02475-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T23:03:17Z","timestamp":1655247797000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-022-02475-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,14]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2475"],"URL":"https:\/\/doi.org\/10.1186\/s12886-022-02475-y","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,14]]},"assertion":[{"value":"27 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The tenets of the Declaration of Helsinki were followed, and informed consent or assent was obtained in written form from all individuals. The research was approved by the institutional review board at the University of Pennsylvania.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"266"}}